Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus on SGLT 2 Inhibitor Therapy in Singapore

Study identifier:D1843R00258

ClinicalTrials.gov identifier:NCT02578563

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

SGLT2 inhibitor Registry in Singapore

Medical condition

Diabetes Mellitus

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

201

Study type

Observational

Age

18 Years - 75 Years

Date

Study Start Date: 12 Feb 2016
Primary Completion Date: 31 Dec 2018
Study Completion Date: 31 Dec 2018

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2019 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria